← Leaderboards
Kenneth A Fields
University Of Kentucky
$10,851,574
Attributed
$11,043,234
Total exposure
12
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,043,234 · 12
By mechanism
R01$7,372,172 · 2
R21$2,865,941 · 7
R56$383,321 · 1
K22$268,800 · 1
R03$153,000 · 1
Top collaborators
- Gregory V Plano1 shared
Most similar at University Of Kentucky
Same institution · by research overlap
- Katerina Wolf$997,250
- Preetha Shridas$2,068,078
Others in their field
Top investigators on “Chlamydia”
- Bala Raja · Luminostics, Inc.$28,624,460
- Michael N Starnbach · Harvard University (Medical School)$24,145,144
- Toni Darville · Univ Of North Carolina Chapel Hill$22,106,685
- Guangming Zhong · University Of Texas Hlth Sci Ctr San Ant$21,380,841
- Nabila El-Bassel · Columbia Univ New York Morningside$20,164,900
- Deborah Anne Dean · Children'S Hospital &Res Ctr At Oakland$15,916,999
Research focus
ChlamydiaPathogenesisDesignInfectionMolecularChlamydia TrachomatisProteinsCellsPathogenVirulenceChlamydia InfectionsChronic DiseasePrevalenceObligate Intracellular ParasiteMemberMediatingSocioeconomicsGeneticSexually Transmitted DiseasesType Iii Secretion System PathwayBiologyCellular BiologyAcute DiseaseComparative
Grant awards (38)
Chlamydia type III effectors affecting the host actin-based cytoskeleton$543,958
R01 · FY2025 · AI · contact PI
Saturating transposon mutagenesis for Chlamydia$189,966
R21 · FY2025 · AI · contact PI
Role of putative cytotoxins in Chlamydia infection$186,094
R21 · FY2025 · AI · contact PI
Chlamydia type III effectors affecting the host actin-based cytoskeleton$560,781
R01 · FY2024 · AI · contact PI
Saturating transposon mutagenesis for Chlamydia$220,303
R21 · FY2024 · AI · contact PI
Role of putative cytotoxins in Chlamydia infection$215,453
R21 · FY2024 · AI · contact PI
Addressing genetic tractability and species-specific infection biology in Chlamydia pneumoniae$191,250
R21 · FY2024 · AI · contact PI
Chlamydia type III effectors affecting the host actin-based cytoskeleton$574,031
R01 · FY2023 · AI · contact PI
Addressing genetic tractability and species-specific infection biology in Chlamydia pneumoniae$229,500
R21 · FY2023 · AI · contact PI
Type III exported effectors of Chlamydia trachomatis$450,070
R01 · FY2021 · AI · contact PI
Engineered promoters for finely tuned gene expression in Chlamydia$76,500
R03 · FY2021 · AI · contact PI
Type III exported effectors of Chlamydia trachomatis$450,070
R01 · FY2020 · AI · contact PI
Conditional Null Mutants in the Study Essential Gene Products of Chlamydia$191,250
R21 · FY2020 · AI · contact PI
Engineered promoters for finely tuned gene expression in Chlamydia$76,500
R03 · FY2020 · AI · contact PI
Type III exported effectors of Chlamydia trachomatis$450,070
R01 · FY2019 · AI · contact PI
Conditional Null Mutants in the Study Essential Gene Products of Chlamydia$214,766
R21 · FY2019 · AI · contact PI
Type III exported effectors of Chlamydia trachomatis$450,070
R01 · FY2018 · AI · contact PI
Type III exported effectors of Chlamydia trachomatis$450,070
R01 · FY2017 · AI · contact PI
Mutagenesis in Chlamydia trachomatis via allelic exchange$188,125
R21 · FY2017 · AI · contact PI
Mutagenesis in Chlamydia trachomatis via allelic exchange$221,003
R21 · FY2016 · AI · contact PI
The role of Perforin-2 in Chlamydia pathogenesis$383,321
R56 · FY2015 · AI · contact PI
Type III exported effectors of Chlamydia trachomatis$371,250
R01 · FY2014 · AI · contact PI
Type III exported effectors of Chlamydia trachomatis$198,315
R01 · FY2013 · AI · contact PI
Type III exported effectors of Chlamydia trachomatis$153,674
R01 · FY2013 · AI · contact PI
Type III exported effectors of Chlamydia trachomatis$378,675
R01 · FY2012 · AI · contact PI
The role of disulfide bonding in type III secretion of Chlamydia spp.$191,250
R21 · FY2012 · AI · contact PI
Type III exported effectors of Chlamydia trachomatis$378,675
R01 · FY2011 · AI · contact PI
The role of disulfide bonding in type III secretion of Chlamydia spp.$220,465
R21 · FY2011 · AI · contact PI
Type III exported effectors of Chlamydia trachomatis$382,500
R01 · FY2010 · AI · contact PI
Type III exported effectors of Chlamydia trachomatis$317,071
R01 · FY2009 · AI · contact PI
Type III exported effectors of Chlamydia trachomatis$317,071
R01 · FY2008 · AI · contact PI
Chlamydia pneumoniae-Specific Inclusion Membrane Proteins$187,616
R21 · FY2008 · AI · contact PI
Type III exported effectors of Chlamydia trachomatis$323,212
R01 · FY2007 · AI · contact PI
Chlamydia pneumoniae-Specific Inclusion Membrane Proteins$218,900
R21 · FY2007 · AI · contact PI
Type III exported effectors of Chlamydia trachomatis$332,865
R01 · FY2006 · AI · contact PI
Type III exported effectors of Chlamydia trachomatis$289,744
R01 · FY2005 · AI
Analysis of type III secreted proteins of C. trachomatis$108,000
K22 · FY2005 · AI
Analysis of type III secreted proteins of C. trachomatis$160,800
K22 · FY2004 · AI